|View printer-friendly version|
|POZEN Announces March 9, 2011 Webcast of Fourth Quarter & Year End 2010 Results|
CHAPEL HILL, N.C., Feb 24, 2011 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ: POZN),announced today that it plans to release fourth quarter and year end 2010 results on March 9, 2011, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m. (EST) with a discussion by POZEN management of the earnings and business results. The webcast can be accessed on POZEN's website at www.pozen.com and will be archived and available for replay. The fourth quarter and year end 2010 earnings release will be accessible in the News section of POZEN's website.
POZEN Inc. is a progressive pharmaceutical company that is transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and a focus on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years - something almost no other small pharmaceutical company has done. Funded by these two milestone/royalty streams, POZEN is now creating a portfolio of cost-effective integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI toxicity. The lead candidate, PA32540, is being investigated for the secondary prevention of cardiovascular disease and has entered Phase 3 clinical trials. POZEN is retaining commercial control of the pipeline assets and will launch creatively using a new sales force model and digital communications. The Company's common stock is traded on The NASDAQ Stock Market under the symbol "POZN". For more detailed company information, including copies of this and other press releases, please visit: www.pozen.com.
SOURCE: POZEN Inc.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.